 "Top intraday picks from Geojit BNP Paribas")
SUN PHARMACEUTICALS INDUSTRIES (Rs 820.15)
Support at Rs 817 below Rs 811. Resistance is at Rs 824.75 above Rs 827.50. (Expect higher level profit booking)
[STOCHASTICS SELL + VOLUME JUMP + BELOW MOVING AVERAGES]
ORCHID PHARMA (Rs 65.25)
Support at Rs 64.10 below Rs 63.50. Resistance is at Rs 67.75 above Rs 72.50. (Buy for intraday with a stoploss below Rs 63.50)
[VOLUME JUMP + ABV MOVING AVERAGES + ABV PREVIOUS CLOSE]
More From This Section
R S SOFTWARE (INDIA) (Rs 144.25)
Support at Rs 141 below Rs 138. Resistance is at Rs 147.50 above Rs 151. (Buy for intraday with a stoploss below Rs 138)
[MACD & STOCHASTICS BUY + VOLUME JUMP]
NAHAR SPINNING MILLS (Rs 131.20)
Support at Rs 129.10 below Rs 127. Resistance is at Rs 133.75 above Rs 135.50 (Buy for intraday with a stoploss below Rs 127)
[MACD & STOCHASTICS BUY+ VOLUME JUMP+ ABV MOVING AVERAGES]
UCAL FUEL SYSTEMS (Rs 137.45)
Support at Rs 136 below Rs 133.90. Resistance is at Rs 140.75 above Rs 144. (Buy for intraday with a stoploss below Rs 133.90)
[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.